J Neurol Surg B Skull Base 2024; 85(S 01): S1-S398
DOI: 10.1055/s-0044-1779997
Presentation Abstracts
Oral Abstracts

Crooke Cell Adenoma Confers Poorer Endocrinologic Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis

Matt Findlay
1   University of Utah, Salt Lake City, Utah, United States
,
Richard Drexler
2   University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Mohammed Azab
3   Boise State University, Boise, Idaho, United States
,
Arian Karbe
2   University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Roman Rotermund
2   University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Franz Ricklefs
2   University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Jörg Flitsch
2   University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Timothy Smith
4   Brigham and Women's Hospital, Boston, Massachusetts, United States
,
John Kilgallon
4   Brigham and Women's Hospital, Boston, Massachusetts, United States
,
Jürgen Honegger
5   University Hospital Tübingen, Tübingen, Germany
,
Isabella Nasi-Kordhishti
5   University Hospital Tübingen, Tübingen, Germany
,
Paul Gardner
6   University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
,
Zachary Gersey
6   University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
,
Hussein Abdallah
6   University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
,
John Jane
7   University of Virginia Health System, Charlottesville, Virginia, United States
,
Alexandria Marino
7   University of Virginia Health System, Charlottesville, Virginia, United States
,
Ulrich Knappe
8   Johannes Wesling Hospital Minden, Minden, Germany
,
Nesrin Uksul
8   Johannes Wesling Hospital Minden, Minden, Germany
,
Jamil Rzaev
9   Novosibirsk State Medical University, Novosibirsk, Russia
,
Anatoliy Bervitskiy
9   Novosibirsk State Medical University, Novosibirsk, Russia
,
Henry Schroeder
10   University Medicine Greifswald, Greifswald, Germany
,
Márton Eördögh
10   University Medicine Greifswald, Greifswald, Germany
,
Marco Losa
11   I.R.C.C.S. San Raffaele Scientific Institute
,
Pietro Mortini
11   I.R.C.C.S. San Raffaele Scientific Institute
,
Rüdiger Gerlach
12   Helios Kliniken, Berlin, Deutschland
,
Apio Antunes
13   Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
,
William Couldwell
1   University of Utah, Salt Lake City, Utah, United States
,
Karol Budohoski
1   University of Utah, Salt Lake City, Utah, United States
,
Robert Rennert
1   University of Utah, Salt Lake City, Utah, United States
,
Michael Karsy
14   Global Neurosciences Institute, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
› Author Affiliations
 
 

    Background: Crooke cell adenomas (CCA) are a rare, aggressive subset of adrenocorticotrophin secreting pituitary corticotroph adenomas (sCTA) found in 5 to 10% of patients with Cushing’s disease. Multiple studies support worse outcomes in CCA but are limited by small sample size and single-institution databases. We compared outcomes in CCA and sCTA using a multicenter, international retrospective database of high-volume skull base centers.

    Methods: Patients surgically treated for pituitary adenoma from January 2017 through December 2020 were included.

    Results: A total of 2,826 patients from 12 international centers were compared (n = 20 CCA and n = 480 sCTA). No difference in baseline demographics, tumor characteristics or postoperative complications was seen. Microsurgical approaches (60% CCA vs. 62.3% sCTA) were most common. Gross total resection (GTR) was higher in CCA patients (100 vs. 83%, p = 0.05). Among patients who had GTR according to intraoperative findings, fewer CCA patients had postoperative hormone normalization of pituitary function (50 vs. 77.8%, p < 0.01) and remission of hypersecretion by 3 to 6 months (75 vs. 84.3%, p < 0.01). This was present despite CCA having better local control rates (100 vs. 96%, p < 0.01) and fewer patients with remnant on MRI (0 vs. 7.2%, p < 0.01). A systematic literature review of 35 studies reporting on various treatment strategies reiterated the high rate of residual tumor, persistent hypercortisolism, and tumor-related mortality in CCA patients.

    Conclusion: This modern, multicenter series of patients with CCA reflects their poor prognosis and reduced postsurgical hormonal normalization. Further work is necessary to better understand the pathophysiology of CCA to devise more targeted treatment approaches ([Figs. 1], [2]).

    Zoom
    Fig. 1
    Zoom
    Fig. 2

    No conflict of interest has been declared by the author(s).

    Publication History

    Article published online:
    05 February 2024

    © 2024. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany

     
    Zoom
    Fig. 1
    Zoom
    Fig. 2